Top news of the week: 18.08.2021.
Companies And Industries
Eight Months After First FDA Approval, Aurinia Picks Up Two More Candidates
The Canadian biotech announced the acquisition of two new pipeline assets that align with its focus on autoimmune and kidney-related disease.
Clinical Catch-Up: August 9-13
There was plenty of clinical trial updates last week. Here’s a look.
Indian Immunologicals receive manufacturing license under Department of Biotechnology - Mission Covid Suraksha Project for Augmentation of Manufacturing Capacity for COVAXIN
Department of Biotechnology and BIRAC under the Mission Covid Suraksha announced by the Government o
‘Freezer burn’ is a serious problem – preventing ice recrystallization may alleviate it
Scientists are looking for safe new ways to prevent ice from damaging food in frozen storage, which costs consumers billions of dollars a year in wasted food.
The 7-year itch? Boehringer culls $600M cancer pact with CureVac, heaping more woe to the biotech
Back in 2014, a German pharma and a then largely unknown fellow German biotech in CureVac penned a $600 million mRNA cancer pact. Buried in financials posted Monday morning, CureVac quietly ...
Bharat Biotech's intranasal Covid vaccine gets nod for phase II trials
India News: HYDERABAD: India’s first intra-nasal Covid-19 vaccine candidate BBV154, which is being developed by Bharat Biotech along with the Washington Universit.
FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing
Rocket Pharmaceuticals’ gene therapy trial is back on track. With the FDA lifting the clinical hold after Rocket changed the study protocol, the biotech is now on course to start dosing ...
Untargeted metabolomics of purple and orange-fleshed sweet potatoes reveals a large structural diversity of anthocyanins and flavonoids
Anthocyanins are economically valuable phytochemicals of significant relevance to human health. Industrially extracted from multiple fruit and vegetable sources, anthocyanin yield and ...